165 related articles for article (PubMed ID: 5369242)
1. Schizophrenia and pink spot.
Stam FC; Heslinga FJ; van Tilburg W
Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242
[No Abstract] [Full Text] [Related]
2. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"].
Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A
Encephale; 1969; 58(4):360-76. PubMed ID: 5378191
[No Abstract] [Full Text] [Related]
3. The identity of the so-called pink spot in schizophrenia and Parkinson's disease.
Heslinga FJ; van Tilburg W; Stam FC
Psychiatr Neurol Neurochir; 1970; 73(3):157-64. PubMed ID: 5310324
[No Abstract] [Full Text] [Related]
4. Diminution of phenethylamine in the urine of Parkinson patients.
Heller B; Fischer E
Arzneimittelforschung; 1973 Jun; 23(6):884-6. PubMed ID: 4740778
[No Abstract] [Full Text] [Related]
5. [Excretion of 3,4-dimethoxy phenylethylamine in the urine of schizophrenics].
Zimmermann K; Moschke P; Wieder KH
Psychiatr Neurol Med Psychol (Leipz); 1976 Mar; 28(3):163-73. PubMed ID: 967948
[TBL] [Abstract][Full Text] [Related]
6. Pink spot in schizophrenia.
Br Med J; 1966 Jan; 1(5480):119. PubMed ID: 5901567
[No Abstract] [Full Text] [Related]
7. [Determination and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in the urine of acute schizophrenics (author's transl)].
Braun G; Kalbhen DA; Müller J; Vahar-Matiar H
Arch Psychiatr Nervenkr (1970); 1974 Mar; 218(3):195-210. PubMed ID: 4838948
[No Abstract] [Full Text] [Related]
8. Identity of a urinary "pink spot" in schizophrenia and Parkinson's disease.
Boulton AA; Pollitt RJ; Majer JR
Nature; 1967 Jul; 215(5097):132-4. PubMed ID: 6049100
[No Abstract] [Full Text] [Related]
9. The pink spot: a red herring?
Lancet; 1966 Oct; 2(7468):848-9. PubMed ID: 4162179
[No Abstract] [Full Text] [Related]
10. Urinary metabolites in Parkinson's disease.
Kuehl FA; Vandenheuvel WJ; Ormond RE
Nature; 1968 Jan; 217(5124):136-8. PubMed ID: 5638146
[No Abstract] [Full Text] [Related]
11. The "pink spot" and schizophrenia.
Pue AF; Hoare R; Adamson JD
Can Psychiatr Assoc J; 1969 Aug; 14(4):397-401. PubMed ID: 5811248
[No Abstract] [Full Text] [Related]
12. A pink spot in thyrotoxicosis.
Widelitz M; Feldman W
Biol Psychiatry; 1971; 3(2):181-4. PubMed ID: 5089913
[No Abstract] [Full Text] [Related]
13. [Biochemical studies in schizophrenia. On the "pink spot" phenomenon].
Vogel WH
Munch Med Wochenschr; 1967 Aug; 109(31):1633-41. PubMed ID: 5631559
[No Abstract] [Full Text] [Related]
14. Beta-phenylethylamine in human urine.
Fischer E; Heller B; Miró AH
Arzneimittelforschung; 1968 Nov; 18(11):1486. PubMed ID: 5755919
[No Abstract] [Full Text] [Related]
15. Pink spot in childhood schizophrenia.
Widelitz MM; Feldman W
Behav Neuropsychiatry; 1969 Apr; 1(1):29-30. PubMed ID: 5398088
[No Abstract] [Full Text] [Related]
16. "Pink spot" and schizophrenia.
Ridges AP; Bourdillon RE; Leslie SA; Harper P
Psychiatr Clin (Basel); 1968; 1(1):44-62. PubMed ID: 4880076
[No Abstract] [Full Text] [Related]
17. 3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia.
Narasimhachari N
Biol Psychiatry; 1979 Feb; 14(1):215-9. PubMed ID: 420902
[No Abstract] [Full Text] [Related]
18. [Significance and identification of 3,4-dimethoxyphenylethylamine in the urine of schizophrenic patients (pink spot reaction)].
Stanciu E; Csiky K; Rácz E
Neurol Psihiatr Neurochir; 1971; 16(4):305-12. PubMed ID: 5118389
[No Abstract] [Full Text] [Related]
19. Is brain damage the cause of "pink spot"?
Nunn RF; Wheeler RH
Nature; 1966 Nov; 212(5065):939. PubMed ID: 6004582
[No Abstract] [Full Text] [Related]
20. Experimental data to the pathogenesis of cryptopyrrole excretion in schizophrenia, I.
Huszák I; Durkó I; Karsai K
Acta Physiol Acad Sci Hung; 1972; 42(1):79-86. PubMed ID: 4664398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
